R. Heijkants

发表

Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer

C. Cui, C. Sier, C. Theuer, 2016, Oncogene.

Selective PKCδ Inhibitor B106 Elicits Uveal Melanoma Growth Inhibitory Effects Independent of Activated PKC Isoforms.

H. Ovaa, A. Jochemsen, A. Teunisse, 2018, ACS chemical biology.

MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells

A. Jochemsen, S. Kiełbasa, H. Mei, 2022, Cancers.

Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target

E. Jordanova, A. Jochemsen, A. Teunisse, 2018, The Journal of pathology.

Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy

S. H. van der Burg, A. Jochemsen, R. Verdijk, 2016, Oncotarget.

Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors

M. Goumans, J. Jonkers, P. ten Dijke, 2015, Clinical Cancer Research.

Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies

A. Jochemsen, A. Teunisse, R. Heijkants, 2018, Oncogenesis.

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma

A. Jochemsen, J. Marine, A. Teunisse, 2017, Oncotarget.